[Federal Register Volume 67, Number 95 (Thursday, May 16, 2002)]
[Notices]
[Pages 34946-34947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-12218]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 34947]]


    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Rapid Response Grant Program on 
Bioterrorism-Related Research (Meeting 1)
    Date: June 5-7, 2002.
    Time: June 5, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency, One Metro Center, Bethesda, MD 20814.
    Time: June 6, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency, One Metro Center, Bethesda, MD 20814.
    Time: June 7, 2002, 8:30 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency, One Metro Center, Bethesda, MD 20814.
    Contact Person: Gregory P. Jarosik, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 
20892, 301-496-2550, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Rapid Response Grant Program on 
Bioterrorism-Related Research (Meeting 2)
    Date: June 10-22, 2002.
    Time: June 10, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Four Points Sheraton, 8400 Wisconsin Avenue, Bethesda, MD 
20814.
    Time: June 11, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Four Points Sheraton, 8400 Wisconsin Avenue, Bethesda, MD 
20814.
    Time: June 12, 2002, 8:30 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Four Points Sheraton, 8400 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Adriana Costero, PhD, Scientific Review 
Administrator, Scientific Review Program, DEA, National Inst. of 
Allergy & Infectious Diseases, National Institutes of Health, 6700 B 
Rockledge Drive, Room 2148F, MSC 7616, Bethesda, MD 20892, 301-496-
2550, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Rapid Response Grant Program on 
Bioterrorism-Related Research (Meeting 3)
    Date: June 12-14, 2002.
    Time: June 12, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, 
MD 20814.
    Time: June 13, 2002, 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, 
MD 20814.
    Time: June 14, 2002, 8:30 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, 
MD 20814.
    Contact Person: Gregory P. Jarosik, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 
20892, 301-496-2550, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: May 9, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-12218 Filed 5-15-02; 8:45 am]
BILLING CODE 4140-01-M